Newer Oral Anticoagulants Beneficial for Atrial Fibrillation | News Brief

In patients with atrial fibrillation (AF), novel oral anticoagulants (NOACs) appear to provide greater overall clinical benefit when compared with vitamin K antagonists. A systematic review and meta-analysis found than NOACs were associated with lower rates of total mortality, cardiovascular mortality, stroke, and systemic embolism in patients with AF when compared with vitamin K antagonists.

Abstract: Circulation, November 13, 2012.


From our CME partner, AKH Inc.

CME: Lipids and Cardiovascular Disease
CME Credit: 1.0 hour activity

The content of this activity was initially presented live at the 2014 ISSFAL Congress held in Stockholm, Sweden.  Topics Include Mediterranean Diet, Milk Fat Globule Membrane (MFGM), DHA Fatty Acid, and Omega-3 Index in Heart Failure Patients.

eMedia - Primary Care




Physician's Weekly for Current Medical News, Events & Issues